• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, January 18, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Researchers link cellular transport pathway to aggressive brain cancer

Bioengineer by Bioengineer
January 14, 2021
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: ©2021 Kulasekaran et al. Originally published in Journal of Cell Biology. https://doi.org/10.1083/jcb.202004229

Researchers at McGill University have identified a new cellular pathway that limits the growth and spread of brain tumors by controlling the recycling of cell surface receptor proteins. The study, which will be published January 14 in the Journal of Cell Biology (JCB), suggests that the pathway, which involves a protein called Rab35, is defective in many patients with glioblastoma and that restoring Rab35’s activity could be a new therapeutic strategy for this deadly form of brain cancer.

Glioblastoma is the most aggressive type of brain cancer, and because it is largely untreatable, the average patient dies within 14 months of diagnosis. Like in other cancers, the proliferation and spread of glioblastoma cells depends on various receptor proteins on the outside of the cell. The levels of these receptor proteins are controlled by cellular transport pathways that internalize the receptors and then either degrade them or return them to the cell surface.

In normal, healthy cells, these transport pathways are regulated by a class of protein known as small GTPases. “We previously demonstrated that the levels of a small GTPase called Rab35 are decreased in human glioblastomas,” says Peter S. McPherson, Director of The Neurodegenerative Disease Research Group at The Neuro (Montreal Neurological Institute-Hospital), McGill University. “We thus sought to investigate the role of Rab35 in the progression of glioblastoma.”

McPherson and colleagues found that reducing the levels of Rab35 increased the growth and spread of brain tumors in mice, thereby shortening the animals’ life span. In contrast, elevating Rab35 levels reduced tumor growth and prolonged the animals’ survival.

The researchers discovered that Rab35 is activated by a pathway involving another small GTPase called Arf5. Together, Arf5 and Rab35 appear to control the transport of various cell surface receptors, thereby restricting the ability of cells to migrate and invade through tissues, and limiting the ability of brain tumor-initiating cells to replicate.

One of the cell surface receptors controlled by this pathway is the signaling protein epidermal growth factor receptor (EGFR). In glioblastoma cells lacking Rab35, EGFR is increasingly recycled to the cell surface instead of being degraded, enhancing the receptor’s signaling activity. Inhibiting EGFR with the cancer drug erlotinib reduced the production of a protein called SPOCD1, which is known to promote the proliferation and/or metastasis of multiple cancers.

McPherson and colleagues suggest that restoring the activity of Rab35 might limit the development of glioblastomas by altering the degradation and recycling of multiple cell surface receptors, including EGFR.

“Rab GTPases are emerging as an important new set of drug targets in cancer,” McPherson says. “Our study reveals an unprecedented link between Rab and Arf proteins and identifies new loci for therapeutic intervention in glioblastoma.”

 

###

Kulasekaran et al., 2021. J. Cell Biol. https://rupress.org/jcb/article-lookup/doi/10.1083/jcb.202004229?PR

About the Journal of Cell Biology The Journal of Cell Biology (JCB) features peer-reviewed research on all aspects of cellular structure and function. All editorial decisions are made by research-active scientists in conjunction with in-house scientific editors. JCB makes all of its content free online no later than six months after publication. Established in 1955, JCB is published by the Rockefeller University Press. For more information, visit https://rupress.org/jcb“>jcb.org.

Visit our http://rupress.org/newsroom“>Newsroom, and sign up for a weekly preview of articles to be published. Embargoed media alerts are for journalists only.

Follow JCB on Twitter at https://twitter.com/jcellbiol“>@JCellBiol and https://twitter.com/rockupress“>@RockUPress.

Media Contact
Ben Short
[email protected]

Original Source

https://rupress.org/jcb/article-lookup/doi/10.1083/jcb.202004229?PR

Related Journal Article

http://dx.doi.org/10.1083/jcb.202004229

Tags: cancerCell BiologyMedicine/Healthneurobiology
Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Tool that predicts if chemotherapy will produce debilitating side effects in older adults

January 14, 2021
IMAGE

New insights into pancreatitis

January 14, 2021

Bladder cancer — When to use chemotherapy

January 14, 2021

Study shows sharp decline in cancer screenings, diagnoses during the first COVID-19 surge

January 14, 2021
Next Post
IMAGE

New suspicious lesions on breast MRI in neoadjuvant therapy

IMAGE

Scientists are a step closer to developing 'smart' stem cells - made from human fat

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    53 shares
    Share 21 Tweet 13
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11
  • New drug form may help treat osteoporosis, calcium-related disorders

    39 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Chemistry/Physics/Materials SciencesTechnology/Engineering/Computer ScienceCell BiologycancerPublic HealthMaterialsClimate ChangeGeneticsEcology/EnvironmentMedicine/HealthBiologyInfectious/Emerging Diseases

Recent Posts

  • Eliminating microplastics in wastewater directly at the source
  • Where COVID-19 hit hardest, sudden deaths outside the hospital increased
  • Many parents say teens with anxiety, depression may benefit from peer confidants at school
  • Scientists shed light on how and why some people report “hearing the dead”
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In